Utilization of 5′ substituted nucleosides for resistance formation in cytoclastic treatment, and drug containing these nucleosides, polymers, methods of use and compositions
作者： Angela Steinkamp-Zucht , Rudolf Fahrig
DOI:
关键词:
摘要: The invention relates to a method of producing composition and for preventing or reducing formation resistance in cytostatic treatment comprising combining BVDU, salt thereof BVDU protected form prodrug with at least one agent order prevent reduce the during treatment. present is also directed delivering therapeutically-effective amount therapeutically effective thereof, form.
lens.org参考文章(86)
Alok Bhushan, Christopher A. Slapak, Stuart B. Levy, Thomas R. Tritton, Expression ofc-fosPrecedesMDR3in Vincristine and Adriamycin Selected Multidrug Resistant Murine Erythroleukemia Cells Biochemical and Biophysical Research Communications. ,vol. 226, pp. 819- 821 ,(1996) , 10.1006/BBRC.1996.1434
Xin-Yuan Guan, Paul S. Meltzer, William S. Dalton, Jeffrey M. Trent, Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection Nature Genetics. ,vol. 8, pp. 155- 161 ,(1994) , 10.1038/NG1094-155
S. Lavi, Carcinogen-mediated amplification of viral DNA sequences in simian virus 40-transformed Chinese hamster embryo cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 78, pp. 6144- 6148 ,(1981) , 10.1073/PNAS.78.10.6144
Rudolf Fahrig, Anti-recombinogenic and convertible co-mutagenic effects of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and other 5-substituted pyrimidine nucleoside analogs in S. cerevisiae MPI Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. ,vol. 372, pp. 133- 139 ,(1996) , 10.1016/S0027-5107(96)00180-7
Murray D Norris, Sharon B Bordow, Glenn M Marshall, Paul S Haber, Susan L Cohn, Michelle Haber, None, Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma The New England Journal of Medicine. ,vol. 334, pp. 231- 238 ,(1996) , 10.1056/NEJM199601253340405
Å Borg, H Sigurdsson, GM Clark, M Fernö, SAW Fuqua, H Olsson, D Killander, WL McGurie, Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. British Journal of Cancer. ,vol. 63, pp. 136- 142 ,(1991) , 10.1038/BJC.1991.28
J. G. M. KLIJN, P. M. J. J. BERNS, P. I. M. SCHMITZ, J. A. FOEKENS, The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients Endocrine Reviews. ,vol. 13, pp. 3- 17 ,(1992) , 10.1210/EDRV-13-1-3
Mohammed Kashani-Sabet, Ying Lu, Lucille Leong, Kay Haedicke, Kevin J. Scanlon, Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil☆ European Journal of Cancer and Clinical Oncology. ,vol. 26, pp. 383- 390 ,(1990) , 10.1016/0277-5379(90)90238-O
Åke Borg, Bo Baldetorp, Mårten Fernö, Håkan Olsson, Helgi Sigurdsson, c-myc amplification is an independent prognostic factor in postmenopausal breast cancer International Journal of Cancer. ,vol. 51, pp. 687- 691 ,(1992) , 10.1002/IJC.2910510504
Michael M. Gottesman, How Cancer Cells Evade Chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture Cancer Research. ,vol. 53, pp. 747- 754 ,(1993)